Extracorporeal Membrane Oxygenation for COVID-19–associated Severe Acute Respiratory Distress Syndrome in Chile
dc.contributor.author | Díaz, Rodrigo A. | |
dc.contributor.author | Graf, Jerónimo | |
dc.contributor.author | Zambrano, José M. | |
dc.contributor.author | Ruiz, Carolina | |
dc.contributor.author | Espinoza, Juan A. | |
dc.contributor.author | Bravo, Sebastián I. | |
dc.contributor.author | Salazar, Pablo A. | |
dc.contributor.author | Bahamondes, Juan C. | |
dc.contributor.author | Castillo, Luis B. | |
dc.contributor.author | Gajardo, Abraham I.J. | |
dc.contributor.author | Kursbaum, Andrés | |
dc.contributor.author | Ferreira, Leonila L. | |
dc.contributor.author | Valenzuela, Josefa | |
dc.contributor.author | Castillo, Roberto E. | |
dc.contributor.author | Pérez-Araos, Rodrigo | |
dc.contributor.author | Bravo, Marcela | |
dc.contributor.author | Aquevedo, Andrés F. | |
dc.contributor.author | González, Mauricio G. | |
dc.contributor.author | Pereira, Rodrigo | |
dc.contributor.author | Ortega, Leandro | |
dc.contributor.author | Santis, Cesar | |
dc.contributor.author | Fernández, Paula A. | |
dc.contributor.author | Cortés, Vilma | |
dc.contributor.author | Cornejo, Rodrigo A. | |
dc.date.accessioned | 2022-03-29T14:52:48Z | |
dc.date.available | 2022-03-29T14:52:48Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Rationale: The role of and needs for extracorporeal membrane oxygenation (ECMO) at a population level during the coronavirus disease (COVID-19) pandemic have not been completely established. Objectives: To identify the cumulative incidence of ECMO use in the first pandemic wave and to describe the Nationwide Chilean cohort of ECMO-supported patients with COVID-19. Methods: We conducted a population-based study from March 3 to August 31, 2020, using linked data from national agencies. The cumulative incidence of ECMO use and mortality risk of ECMO-supported patients were calculated and age standardized. In addition, a retrospective cohort analysis was performed. Outcomes were 90-day mortality after ECMO initiation, ECMO-associated complications, and hospital length of stay. Cox regression models were used to explore risk factors for mortality in a time-to-event analysis. Measurements and Main Results: Ninety-four patients with COVID-19 were supported with ECMO (0.42 per population of 100,000, 14.89 per 100,000 positive cases, and 1.2% of intubated patients with COVID-19); 85 were included in the cohort analysis, and the median age was 48 (interquartile range [IQR], 41-55) years, 83.5% were men, and 42.4% had obesity. The median number of pre-ECMO intubation days was 4 (IQR, 2-7), the median PaO2/FiO2 ratio was 86.8 (IQR, 64-99) mm Hg, 91.8% of patients were prone positioned, and 14 patients had refractory respiratory acidosis. Main complications were infections (70.6%), bleeding (38.8%), and thromboembolism (22.4%); 52 patients were discharged home, and 33 died. The hospital length of stay was a median of 50 (IQR, 24-69) days. Lower respiratory system compliance and higher driving pressure before ECMO initiation were associated with increased mortality. A duration of pre-ECMO intubation ≥10 days was not associated with mortality. Conclusions: Documenting nationwide ECMO needs may help in planning ECMO provision for future COVID-19 pandemic waves. The 90-day mortality of the Chilean cohort of ECMO-supported patients with COVID-19 (38.8%) is comparable to that of previous reports. | es |
dc.description.version | Versión Publicada | es |
dc.identifier.citation | iaz RA, Graf J, Zambrano JM, Ruiz C, Espinoza JA, Bravo SI, Salazar PA, Bahamondes JC, Castillo LB, Gajardo AIJ, Kursbaum A, Ferreira LL, Valenzuela J, Castillo RE, Pérez-Araos RA, Bravo M, Aquevedo AF, González MG, Pereira R, Ortega L, Santis C, Fernández PA, Cortés V, Cornejo RA. Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study. Am J Respir Crit Care Med. 2021 Jul 1;204(1):34-43. doi: 10.1164/rccm.202011-4166OC | es |
dc.identifier.uri | https://doi.org/10.1164/rccm.202011-4166OC | es |
dc.identifier.uri | http://hdl.handle.net/11447/5842 | |
dc.language.iso | en | es |
dc.subject | Extracorporeal membrane oxygenation | es |
dc.subject | Covid-19 | es |
dc.subject | Severe acute respiratory distress syndrome | es |
dc.subject | Pandemic | es |
dc.title | Extracorporeal Membrane Oxygenation for COVID-19–associated Severe Acute Respiratory Distress Syndrome in Chile | es |
dc.type | Article | es |
dcterms.source | American Journal of Respiratory and Critical Care Medicine | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- rccm.202011-4166OC.pdf
- Size:
- 775.56 KB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: